Bead arrays for antibody and complement profiling reveal joint contribution of antibody isotypes to C3 deposition

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ayoglu, Burcu ^a   Szarka, Eszter ^b   Huber, Krisztina ^b   Orosz, Anita ^b   Babos, Fruzsina ^c   Magyar, Anna ^c   Hudecz, Ferenc ^b,c   Rojkovich, Bernadette ^d   Gáti, Tamás ^d   Nagy, György ^d,e   Schwenk, Jochen M ^a   Sármay, Gabriella ^b   Prechl, József ^f,g   Nilsson, Peter ^a   Papp, Krisztián ^a,f  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d Department of Organic Chemistry Eötvös Loránd University ^*  (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f MTA ELTE Immunology Research Group Eötvös University   (Hungary)

^g Diagnosticum Ltd   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRULLINATED FIBRINOGEN BETA; CITRULLINATED PEPTIDE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1; FIBRINOGEN; FILAGGRIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; ANTIGEN; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN CLASS;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT COMPONENT C3 BLOOD LEVEL; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN ISOTYPES; MALE; MIDDLE AGED; RHEUMATOID FACTOR;

EID: 84900387101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096403     Document Type: Article

References (46)

1. Price JV, Haddon DJ, Kemmer D, Delepine G, Mandelbaum G, et al. (2013) Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest 123: 5135-5145.
2. Ayoglu B, Haggmark A, Khademi M, Olsson T, Uhlen M, et al. (2013) Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol Cell Proteomics 12: 2657-2672.
3. Miersch S, Bian X, Wallstrom G, Sibani S, Logvinenko T, et al. (2013) Serological autoantibody profiling of type 1 diabetes by protein arrays. J Proteomics 94: 486-496.
4. Prechl J, Papp K, Erdei A (2010) Antigen microarrays: descriptive chemistry or functional immunomics? Trends Immunol 31: 133-137.
5. Dunkelberger JR, Song WC (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20: 34-50.
6. Walport MJ (2001) Complement. First of two parts. N Engl J Med 344: 1058-1066.
7. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7: 429-442. (Pubitemid 46834849)
8. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, et al. (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. Journal of immunology (Baltimore, Md: 1950) 166: 4177-4184.
9. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. The Journal of clinical investigation 101: 273-281. (Pubitemid 28058927)
10. Jónsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Annals of the rheumatic diseases 52: 161-164. (Pubitemid 23065680)
11. Shmerling RH, Delbanco TL (1991) The rheumatoid factor: an analysis of clinical utility. The American journal of medicine 91: 528-534.
12. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, et al. (2010) Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunological reviews 233: 34-54.
13. Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, et al. (1993) The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest 92: 1387-1393. (Pubitemid 23273915)
14. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, et al. (2006) Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. European journal of immunology 36: 2250-2263. (Pubitemid 44251769)
15. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373: 659-672.
16. Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P (2006) Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis and rheumatism 54: 733-741.
17. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, et al. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688.
18. Paramita DK, Fatmawati C, Juwana H, Schaijk FGV, Fachiroh J, et al. (2011) Humoral Immune Responses to Epstein - Barr Virus Encoded Tumor Associated Proteins and Their Putative Extracellular Domains in Nasopharyngeal Carcinoma Patients and Regional Controls. 678: 665-678.
19. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768. (Pubitemid 39331148)
20. Drobin K, Nilsson P, Schwenk JM (2013) Highly multiplexed antibody suspension bead arrays for plasma protein profiling. Methods Mol Biol 1023: 137-145.
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588.
22. Babos F, Szarka E, Nagy G, Majer Z, Sarmay G, et al. (2013) Role of N- or Cterminal biotinylation in autoantibody recognition of citrullin containing filaggrin epitope peptides in rheumatoid arthritis. Bioconjug Chem 24: 817-827.
23. Bartos A, Uray K, Hudecz F (2009) New biotin derivatives for labeling and solubilizing IgG peptides. Biopolymers 92: 110-115.
24. Team RDC (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing.
25. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, et al. (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167: 2861-2868. (Pubitemid 32768920)
26. Seino J, Eveleigh P, Warnaar S, van Haarlem LJ, van Es LA, et al. (1993) Activation of human complement by mouse and mouse/human chimeric monoclonal antibodies. Clinical and experimental immunology 94: 291-296. (Pubitemid 23337829)
27. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, et al. (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296: 187-198. (Pubitemid 40174752)
28. Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, et al. (2007) Complement analysis in the 21st century. Mol Immunol 44: 3838-3849. (Pubitemid 47337118)
29. Papp K, Szekeres Z, Terenyi N, Isaak A, Erdei A, et al. (2007) On-chip complement activation adds an extra dimension to antigen microarrays. Mol Cell Proteomics 6: 133-140. (Pubitemid 46152698)
30. Wahrmann M, Exner M, Regele H, Derfler K, Körmöczi GF, et al. (2003) Flow cytometry based detection of HLA alloantibody mediated classical complement activation. Journal of Immunological Methods 275: 149-160. (Pubitemid 36351550)
31. Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, et al. (2005) [C4d]FlowPRA screening - a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Human immunology 66: 526-534. (Pubitemid 40797551)
32. Wahrmann M, Exner M, Schillinger M, Haidbauer B, Regele H, et al. (2006) Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 6: 1033-1041.
33. Wahrmann M, Bartel G, Exner M, Regele H, Körmöczi GF, et al. (2009) Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transplant international: official journal of the European Society for Organ Transplantation 22: 982-989.
34. Smith JD, Hamour IM, Banner NR, Rose ML (2007) C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7: 2809-2815.
35. Chen G, Sequeira F, Tyan DB (2011) Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Human immunology 72: 849-858.
36. Trouw LA, Haisma EM, Levarht EWN, van der Woude D, Ioan-Facsinay A, et al. (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis and rheumatism 60: 1923-1931.
37. Hourcade DE (2006) The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 281: 2128-2132. (Pubitemid 43845802)
38. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004) The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clinical and experimental immunology 138: 439-446. (Pubitemid 39573623)
39. Papp K, Vegh P, Hobor R, Erdei A, Prechl J (2012) Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays. J Immunol Methods 375: 75-83.
40. Okroj M, Heinegård D, Holmdahl R, Blom AM (2007) Rheumatoid arthritis and the complement system. Annals of medicine 39: 517-530. (Pubitemid 350035568)
41. Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, et al. (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Annals of the rheumatic diseases 46: 65-71. (Pubitemid 17225132)
42. Visser H, Gelinck LB, Kampfraath aH, Breedveld FC, Hazes JM (1996) Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis. Annals of the Rheumatic Diseases 55: 157-161. (Pubitemid 26076729)
43. Szarka E, Babos F, Magyar A, Huber K, Szittner Z, et al. (2013) Recognition of new citrulline containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of Rheumatoid arthritis patients. Immunology.
44. Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, et al. (2004) Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. The Journal of infectious diseases 190: 53-62. (Pubitemid 38858404)
45. Henle G, Lennette ET, Alspaugh Ma, Henle W (1979) Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clinical and experimental immunology 36: 415-422. (Pubitemid 9192687)
46. Mathew A, Cheng HM, Sam CK, Prasad U (1994) Serum IgA cross-reactivity between glycine-alanine repeat sequence of EBNA-1 and keratin or collagen in nasopharyngeal carcinoma. Clinical immunology and immunopathology 71: 164-168. (Pubitemid 24147232)